Related Experiment Video
Updated: Apr 19, 2026

Evaluation of Zebrafish Kidney Function Using a Fluorescent Clearance Assay
Published on: February 20, 2015
Cystic gene dosage influences kidney lesions after nephron reduction
Abstract:
Cystic kidney disease is characterized by the progressive development of multiple fluid-filled cysts. Cysts can be acquired, or they may appear during development or in postnatal life due to specific gene defects and lead to renal failure. The most frequent form of this disease is the inherited polycystic kidney disease (PKD). Experimental models of PKD showed that an increase of cellular proliferation and apoptosis as well as defects in apico-basal and planar cell polarity or cilia play a critical role in cyst development. However, little is known about the mechanisms and the mediators involved in acquired cystic kidney diseases (ACKD). In this study, we used the nephron reduction as a model to study the mechanisms underlying cyst development in ACKD. We found that tubular dilations after nephron reduction recapitulated most of the morphological features of ACKD. The development of tubular dilations was associated with a dramatic increase of cell proliferation. In contrast, the apico-basal polarity and cilia did not seem to be affected. Interestingly, polycystin 1 and fibrocystin were markedly increased and polycystin 2 was decreased in cells lining the dilated tubules, whereas the expression of several other cystic genes did not change. More importantly, Pkd1 haploinsufficiency accelerated the development of tubular dilations after nephron reduction, a phenotype that was associated to a further increase of cell proliferation. These data were relevant to humans ACKD, as cystic genes expression and the rate of cell proliferation were also increased. In conclusion, our study suggests that the nephron reduction can be considered a suitable model to study ACKD and that dosage of genes involved in PKD is also important in ACKD.
Insights
Acquired cystic kidney disease (ACKD) mechanisms were studied using a nephron reduction model. This model revealed increased cell proliferation and altered polycystin expression, suggesting gene dosage is crucial in ACKD development.
Area of Science:
- Nephrology
- Molecular Biology
- Genetics
Background:
- Cystic kidney diseases involve progressive cyst development, often leading to renal failure.
- Inherited polycystic kidney disease (PKD) mechanisms involve cell proliferation, apoptosis, and polarity defects.
- Mechanisms underlying acquired cystic kidney diseases (ACKD) remain poorly understood.
Purpose of the Study:
- To investigate the mechanisms of cyst development in acquired cystic kidney diseases (ACKD).
- To utilize the nephron reduction model to study ACKD pathogenesis.
- To explore the role of gene dosage in ACKD.
Main Methods:
- Employed a nephron reduction model to induce and study acquired cystic kidney disease.
- Analyzed morphological features, cell proliferation, apoptosis, and cell polarity markers.
- Assessed the expression of key cystic genes, including polycystins, and evaluated the impact of Pkd1 haploinsufficiency.
Main Results:
- Nephron reduction successfully recapitulated key morphological features of ACKD, characterized by tubular dilations.
- Tubular dilation development was associated with significantly increased cell proliferation but not altered apico-basal polarity or cilia.
- Marked increases in polycystin 1 and fibrocystin, with a decrease in polycystin 2, were observed; Pkd1 haploinsufficiency accelerated ACKD development and further increased cell proliferation.
Conclusions:
- The nephron reduction model is suitable for studying acquired cystic kidney disease mechanisms.
- Cell proliferation plays a critical role in ACKD development.
- Gene dosage of PKD-related genes, such as Pkd1, is important in the pathogenesis of ACKD.
Related Concept Videos
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
Renal Failure: Dose Adjustments
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration
Cystic Fibrosis: Management
Sinus disease and chronic...
Factors Affecting Renal Clearance: Renal Impairment
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...

